NCT04488198 is a NA clinical trial of Acupuncture in Morbus Crohn, sponsored by Medical University of Vienna.

Who is sponsoring NCT04488198?

NCT04488198 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04488198?

Interventions in NCT04488198: Acupuncture, Placebo-Acupuncture.

What condition does NCT04488198 study?

NCT04488198 studies Morbus Crohn, Colitis, Ulcerative.

Is NCT04488198 still recruiting?

NCT04488198 is currently active, enrolled. Last updated 3 October 2025.

Last reviewed 2025-10-03 · How we verify

NCT04488198

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases

Active, enrolled NA Last updated 3 October 2025

What this trial tests

NA trial testing Acupuncture in Morbus Crohn in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 March 2019

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	1 March 2019
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across Austria

Drugs / interventions tested

Acupuncture — full drug profile →
Placebo-Acupuncture

Conditions studied

Morbus Crohn — all drugs for Morbus Crohn →
Colitis, Ulcerative — all drugs for Colitis, Ulcerative →

Sponsor

Medical University of Vienna

Who can join

Adults 10 to 17, any sex, with Morbus Crohn or Colitis, Ulcerative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic inflammatory bowel disease (CIBD) with its prevalence of 2.6 million people in Europe is diagnosed in 25% before the age of 18 years. Early remission is intended to improve child growth, quality of life and reduce psychological comorbidities. Additionally to conventional drugs one third of pediatric CIBD patients use alternative treatment strategies. However, there is a lack of evidence of acupuncture as complementary medicine in pediatric CIBD on the disease activity and inflammation. Therefore, the main aim of this study is to evaluate the effect of acupuncture in children with CIBD on the Pediatric Ulcerative Colitis Activity Index (PUCAI) and the Weighted Pediatric Crohn's Disease Activity Index (sPCDAI), which are non-invasive validated instruments to measure the disease activity. Furthermore, this study aims to investigate the effect of acupuncture on chronic pain, quality of life and parameters of inflammation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for the management of abdominal pain in ulcerative colitis.
Sinopoulou V, Gordon M, Dovey TM, Akobeng AK. · · 2021 · cited 23× · PMID 34291816 · DOI 10.1002/14651858.cd013589.pub2

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

NCT07522567 — Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures · NA · not yet recruiting
NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
NCT07522710 — Clinical Study on Intensive Multi-acupuncture in the Treatment of Neck and Shoulder Myofascial Pain Syndrome · NA · not yet recruiting
NCT07505927 — Acupuncture for Postoperative Gastric Emptying Delay · NA · not yet recruiting
NCT07410793 — Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. · Phase 2 · recruiting

Other recruiting trials for Morbus Crohn

Currently open trials in the same condition.

NCT07338565 — Magnesium in Gastrointestinal Disease · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04488198 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 3 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04488198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing